NCT00754325 2016-05-26Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase InhibitorBristol-Myers SquibbPhase 2 Completed100 enrolled 13 charts